Skip to main content

Fortress Biotech, Inc.

FBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001429260

No open-market purchases or sales by Fortress Biotech, Inc. insiders were filed in the last 90 days; 55 institutions reported holding it in 13F filings for Q2 2026, worth $17.7M in total; no superinvestor holds it.

Other share classesFBIOP

Q2 2021 vs. Q1 2021

How the institutions holding Fortress Biotech, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of FBIO: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders85850
Shares31.3M30.0M−1.26M (−4.0%)
Value$110.4M$107.1M−$3.27M (−3.0%)

New holders (13)

Institutions that held Fortress Biotech, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to FBIO in Q2 2021
InstitutionSharesValue% of portfolio
Susquehanna International Group, LLP48,998$175.0K0.00%
Citadel Advisors LLC45,930$164.0K0.00%
Amalgamated Bank13,527$48.0K0.00%
First Quadrant L P13,200$47.0K0.01%
ExodusPoint Capital Management, LP12,183$43.0K0.00%
Group One Trading, L.P.10,120$36.0K0.00%
Pinz Capital Management, LP5,700$20.0K0.01%
Spire Wealth Management2,000$7.00K0.00%
Phoenix Wealth Advisors800$3.00K0.00%
TCI Wealth Advisors, Inc.646$2.00K0.00%
FMR LLC1$00.00%
Arete Wealth Advisors, LLC11,000$00.00%
Lindbrook Capital, LLC29$00.00%

Sold out (13)

Institutions that held Fortress Biotech, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.